Orthoreoviruses

Fields Virology: Sixth Edition

Volumn 1, Issue , 2013, Pages

  Dermody, Terence S ^a   Parker, John S L ^b   Sherry, Barbara ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cornell University ^*  (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84974725575     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (558)

1. Acs G, Klett H, Schonberg M, et al. Mechanism of reovirus double-stranded RNA synthesis in vivo and in vitro. J Virol 1971;8:684-689.
2. Agosto MA, Ivanovic T, Nibert ML. Mammalian reovirus, a nonfusogenic nonenveloped virus, forms size-selective pores in a model membrane. Proc Natl Acad Sci U S A 2006;103:16496-16501.
3. Agosto MA, Myers KS, Ivanovic T, et al. A positive-feedback mechanism promotes reovirus particle conversion to the intermediate associated with membrane penetration. Proc Natl Acad Sci U S A 2008;105:10571-10576.
4. Ahmed R, Canning WM, Kauffman RS, et al. Role of the host cell in persistent viral infection: coevolution of L cells and reovirus during persistent infection. Cell 1981;25:325-332.
5. Ahmed R, Chakraborty PR, Fields BN. Genetic variation during lytic reovirus infection: high-passage stocks of wild-type reovirus contain temperature-sensitive mutants. J Virol 1980;34:285-287.
6. Ahmed R, Chakraborty PR, Graham AF, et al. Genetic variation during persistent reovirus infection: presence of extragenically suppressed temperature-sensitive lesions in wild-type virus isolated from persistently infected L cells. J Virol 1980;34:383-389.
7. Ahmed R, Fields BN. Reassortment of genome segments between reovirus defective interfering particles and infectious virus: construction of temperature-sensitive and attenuated viruses by rescue of mutations from DI particles. Virology 1981;111:351-363.
8. Ahmed R, Kauffman RS, Fields BN. Genetic variation during persistent reovirus infection: isolation of cold-sensitive and temperature-sensitive mutants from persistently infected L cells. Virology 1983;131:71-78.
9. Alain T, Hirasawa K, Pon KJ, et al. Reovirus therapy of lymphoid malignancies. Blood 2002;100:4146-4153.
10. Alain T, Kim TS, Lun X, et al. Proteolytic disassembly is a critical determinant for reovirus oncolysis. Mol Ther 2007;15:1512-1521.
11. Alloussi SH, Alkassar M, Urbschat S, et al. All reovirus subtypes show oncolytic potential in primary cells of human high-grade glioma. Oncol Rep 2011;26:645-649.
12. Amerongen HM, Wilson GAR, Fields BN, et al. Proteolytic processing of reovirus is required for adherence to intestinal M cells. J Virol 1994;68:8428-8432.
13. Antar AAR, Konopka JL, Campbell JA, et al. Junctional adhesion molecule-A is required for hematogenous dissemination of reovirus. Cell Host Microbe 2009;5:59-71.
14. Antczak JB, Chmelo R, Pickup DJ, et al. Sequences at both termini of the ten genes of reovirus serotype 3 (strain Dearing). Virology 1982;121: 307-319.
15. Antczak JB, Joklik WK. Reovirus genome segment assortment into progeny genomes studied by the use of monoclonal antibodies directed against reovirus proteins. Virology 1992;187:760-776.
16. Arnold MM, Murray KE, Nibert ML. Formation of the factory matrix is an important, though not a sufficient function of nonstructural protein μNS during reovirus infection. Virology 2008;375:412-423.
17. Arnott S, Wilkins MHF, Fuller W, et al. Molecular and crystal structures of double-helical RNA. J Mol Biol 1967;27:525-532.
18. Attoui H, Biagini P, Stirling J, et al. Sequence characterization of Ndelle virus genome segments 1, 5, 7, 8, and 10: evidence for reassignment to the genus Orthoreovirus, family Reoviridae. Biochem Biophys Res Commun 2001;287:583-588.
19. Atwater JA, Munemitsu SM, Samuel CE. Biosynthesis of reovirus-specified polypeptides: efficiency of expression of cDNAs of the reovirus S1 and S4 genes in transfected animal cells differs at the level of translation. Virology 1987;159:350-357.
20. Azzam-Smoak K, Noah DL, Stewart MJ, et al. Interferon regulatory factor-1, interferon-beta, and reovirus-induced myocarditis. Virology 2002;298:20-29.
21. Baer GS, Dermody TS. Mutations in reovirus outer-capsid protein σ3 selected during persistent infections of L cells confer resistance to protease inhibitor E64. J Virol 1997;71:4921-4928.
22. Baer GS, Ebert DH, Chung CJ, et al. Mutant cells selected during persistent reovirus infection do not express mature cathepsin L and do not support reovirus disassembly. J Virol 1999;73:9532-9543.
23. Baglioni C, DeBenedetti A, Williams GJ. Cleavage of nascent reovirus mRNA by localized activation of the 2'-5'-olioadenylate-dependent endoribonuclease. J Virol 1984;52:865-871.
24. Banerjee AK, Shatkin AJ. Guanosine-5'-diphosphate at the 5' termini of reovirus RNA: evidence for a segmented genome within the virion. J Mol Biol 1971;61:643-653.
25. Barkon ML, Haller BL, Virgin HW. Circulating immunoglobulin G can play a critical role in clearance of intestinal reovirus infection. J Virol 1996;70:1109-1116.
26. Barton ES, Connolly JL, Forrest JC, et al. Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening. J Biol Chem 2001;276:2200-2211.
27. Barton ES, Forrest JC, Connolly JL, et al. Junction adhesion molecule is a receptor for reovirus. Cell 2001;104:441-451.
28. Barton ES, Youree BE, Ebert DH, et al. Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease. J Clin Invest 2003;111:1823-1833.
29. Bass DM, Bodkin D, Dambrauskas R, et al. Intraluminal proteolytic activation plays an important role in replication of type 1 reovirus in the intestines of neonatal mice. J Virol 1990;64:1830-1833.
30. Bassel-Duby R, Spriggs DR, Tyler KL, et al. Identification of attenuating mutations on the reovirus type 3 S1 double-stranded RNA segment with a rapid sequencing technique. J Virol 1986;60:64-67.
31. Baty CJ, Sherry B. Cytopathogenic effect in cardiac myocytes but not in cardiac fibroblasts is correlated with reovirus-induced acute myocarditis. J Virol 1993;67:6295-6298.
32. Beattie E, Denzler KL, Tartaglia J, et al. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J Virol 1995;69:499-505.
33. Becker MM, Goral MI, Hazelton PR, et al. Reovirus σNS protein is required for nucleation of viral assembly complexes and formation of viral inclusions. J Virol 2001;75:1459-1475.
34. Becker MM, Peters TR, Dermody TS. Reovirus σNS and μNS proteins form cytoplasmic inclusion structures in the absence of viral infection. J Virol 2003;77:5948-5963.
35. Beckham JD, Goody RJ, Clarke P, et al. Novel strategy for treatment of viral central nervous system infection by using a cell-permeating inhibitor of c-Jun N-terminal kinase. J Virol 2007;81:6984-6992.
36. Beckham JD, Tuttle K, Tyler KL. Reovirus activates transforming growth factor beta and bone morphogenetic protein signaling pathways in the central nervous system that contribute to neuronal survival following infection. J Virol 2009;83:5035-5045.
37. Beckham JD, Tuttle KD, Tyler KL. Caspase-3 activation is required for reovirus-induced encephalitis in vivo. J Neurovirol 2010;16:306-317.
38. Bellamy AR, Hole LV, Baguley BC. Isolation of the trinucleotide ppGpCpU from reovirus. Virology 1970;42:415-420.
39. Bellamy AR, Joklik WK. Studies on the A-rich RNA of reovirus. Proc Natl Acad Sci U S A 1967;58:1389-1395.
40. Bellamy AR, Joklik WK, Shapiro L, et al. Studies on reovirus RNA. I. Characterization of reovirus genome RNA. J Mol Biol 1967;29:1-17.
41. Bellamy AR, Nichols JL, Joklik WK. Nucleotide sequences of reovirus oligonucleotides: evidence for abortive RNA synthesis during virus maturation. Nature 1972;238:49-51.
42. Benavente J, Martinez-Costas J. Avian reovirus: structure and biology. Virus Res 2007;123:105-119.
43. Benavente J, Shatkin AJ. Avian reovirus mRNAs are nonfunctional in infected mouse cells: translational basis for virus host-range restriction. Proc Natl Acad Sci U S A 1988;85:4257-4261.
44. Berard A, Coombs KM. Mammalian reoviruses: propagation, quantification, and storage. Curr Protoc Microbiol 2009;Chapter 15:Unit15C.1.
45. Berens HM, Tyler KL. The proapoptotic Bcl-2 protein Bax plays an important role in the pathogenesis of reovirus encephalitis. J Virol 2011;85:3858-3871.
46. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev lmmunol 1999;17:657-700.
47. Bergeron J, Mabrouk T, Garzon S, et al. Characterization of the thermosensitive ts453 reovirus mutant: increased dsRNA binding of σ3 protein correlates with interferon resistance. Virology 1998;246:199-210.
48. Bessho K, Bezerra JA. Biliary atresia: will blocking inflammation tame the disease? Annu Rev Med 2011;62:171-185.
49. Bharhani MS, Grewal JS, Peppler R, et al. Comprehensive phenotypic analysis of the gut intra-epithelial lymphocyte compartment: perturbations induced by acute reovirus 1/L infection of the gastrointestinal tract. Int Immunol 2007;19:567-579.
50. Bharhani MS, Grewal JS, Pilgrim MJ, et al. Reovirus serotype 1/strain Lang-stimulated activation of antigen-specific T lymphocytes in Peyer's patches and distal gut-mucosal sites: activation status and cytotoxic mechanisms. J Immunol 2005;174:3580-3589.
51. Bisaillon M, Lemay G. Characterization of the reovirus λ1 protein RNA 5'-triphosphatase activity. J Biol Chem 1997;272:29954-29957.
52. Bisaillon M, Lemay G. Molecular dissection of the reovirus λ1 protein nucleic acids binding site. Virus Res 1997;51:231-237.
53. Bodkin DK, Fields BN. Growth and survival of reovirus in intestinal tissue: role of the L2 and S1 genes. J Virol 1989;63:1188-1193.
54. Bodkin DK, Nibert ML, Fields BN. Proteolytic digestion of reovirus in the intestinal lumens of neonatal mice. J Virol 1989;63:4676-4681.
55. Boehme KW, Frierson JM, Konopka JL, et al. The reovirus σ1s protein is a determinant of hematogenous but not neural virus dissemination in mice. J Virol 2011;85:11781-11790.
56. Boehme KW, Guglielmi KM, Dermody TS. Reovirus nonstructural protein σ1s is required for establishment of viremia and systemic dissemination. Proc Natl Acad Sci U S A 2009;106:19986-19991.
57. Boehme KW, Ikizler M, Kobayashi T, et al. Reverse genetics for mammalian reovirus. Methods 2011;55:109-113.
58. Borsa J, Copps TP, Sargent MD, et al. New intermediate subviral particles in the in vitro uncoating of reovirus virions by chymotrypsin. J Virol 1973;11:552-564.
59. Borsa J, Morash BD, Sargent MD, et al. Two modes of entry of reovirus particles into L cells. J Gen Virol 1979;45:161-170.
60. Borsa J, Sargent MD, Lievaart PA, et al. Reovirus: evidence for a second step in the intracellular uncoating and transcriptase activation process. Virology 1981;111:191-200.
61. Both GW, Furuichi Y, Muthukrishnan S, et al. Ribosome binding to reovirus mRNA in protein synthesis requires 5' terminal 7-methylguanosine. Cell 1975;6:185-195.
62. Boutilier J, Duncan R. The reovirus fusion-associated small transmembrane (FAST) proteins: virus-encoded cellular fusogens. Curr Top Membr 2011;68:107-140.
63. Brentano L, Noah DL, Brown EG, et al. The reovirus μ2, encoded by the M1 gene, is an RNA-binding protein. Virology 1998;72:8354-8357.
64. Breun LA, Broering TJ, McCutcheon AM, et al. Mammalian reovirus L2 gene and λ2 core spike protein sequences and whole-genome comparisons of reoviruses type 1 Lang, type 2 Jones, and type 3 Dearing. Virology 2001;287:333-348.
65. Broering TJ, Arnold MM, Miller CL, et al. Carboxyl-proximal regions of reovirus nonstructural protein μNS necessary and sufficient for forming factory-like inclusions. J Virol 2005;79:6194-6206.
66. Broering TJ, Kim J, Miller CL, et al. Reovirus nonstructural protein μNS recruits viral core surface proteins and entering core particles to factory-like inclusions. J Virol 2004;78:1882-1892.
67. Broering TJ, McCutcheon AM, Centonze VE, et al. Reovirus nonstructural protein μNS binds to core particles but does not inhibit their transcription and capping activities. J Virol 2000;74:5516-5524.
68. Broering TJ, Parker JS, Joyce PL, et al. Mammalian reovirus nonstructural protein μNS forms large inclusions and colocalizes with reovirus microtubule-associated protein μ2 in transfected cells. J Virol 2002;76: 8285-8297.
69. Brown CW, Stephenson KB, Hanson S, et al. The p14 FAST protein of reptilian reovirus increases vesicular stomatitis virus neuropathogenesis. J Virol 2009;83:552-561.
70. Brown EG, Nibert ML, Fields BN. The L2 gene of reovirus serotype 3 controls the capacity to interfere, accumulate deletions and establish persistent infection. In: Compans RW, Bishop DHL, eds. Double-stranded RNA Viruses. New York: Elsevier Biomedical, 1983:275-287.
71. Brown WR. Lack of confirmation of the association of reovirus 3 and biliary atresia: methodological differences. Hepatology 1990;12:1254-1255.
72. Brown WR, Sokol RJ, Levin MJ, et al. Lack of correlation between infection with reovirus 3 and extrahepatic biliary. J Pediatr 1988;113:670-676.
73. Buchholz UJ, Finke S, Conzelmann KK. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 1999;73:251-259.
74. Buonavoglia C, Martella V. Canine respiratory viruses. Vet Res 2007;38: 355-373.
75. Burstin SJ, Spriggs DR, Fields BN. Evidence for functional domains on the reovirus type 3 hemagglutinin. Virology 1982;117:146-155.
76. Campbell JA, Shelling P, Wetzel JD, et al. Junctional adhesion molecule-A serves as a receptor for prototype and field-isolate strains of mammalian reovirus. J Virol 2005;79:7967-7978.
77. Carvalho J, Arnold MM, Nibert ML. Silencing and complementation of reovirus core protein μ2: functional correlations with μ2-microtubule association and differences between virus- and plasmid-derived μ2. Virology 2007;364:301-316.
78. Cavalli A, Prota AE, Stehle T, et al. A molecular dynamics study of reovirus attachment protein σ1 reveals conformational changes in σ1 structure. Biophys J 2004;86:3423-3431.
79. Chandran K, Farsetta DL, Nibert ML. Strategy for nonenveloped virus entry: a hydrophobic conformer of the reovirus membrane penetration protein μ1 mediates membrane disruption. J Virol 2002;76:9920-9933.
80. Chandran K, Nibert ML. Protease cleavage of reovirus capsid protein μ1/μ1C is blocked by alkyl sulfate detergents, yielding a new type of infectious subvirion particle. J Virol 1998;72:467-475.
81. Chandran K, Parker JS, Ehrlich M, et al. The delta region of outer-capsid protein μ1 undergoes conformational change and release from reovirus particles during cell entry. J Virol 2003;77:13361-13375.
82. Chandran K, Sullivan NJ, Felbor U, et al. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 2005;308: 1643-1645.
83. Chandran K, Walker SB, Chen Y, et al. In vitro recoating of reovirus cores with baculovirus-expressed outer-capsid proteins μ1 and σ3. J Virol 1999;73:3941-3950.
84. Chandran K, Zhang X, Olson NH, et al. Complete in vitro assembly of the reovirus outer capsid produces highly infectious particles suitable for genetic studies of the receptor-binding protein. J Virol 2001;75:5335-5342.
85. Chang CT, Zweerink HJ. Fate of parental reovirus in infected cell. Virology 1971;46:544-555.
86. Chapman HA, Riese RJ, Shi GP. Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 1997;59:63-88.
87. Chappell JD, Barton ES, Smith TH, et al. Cleavage susceptibility of reovirus attachment protein σ1 during proteolytic disassembly of virions is determined by a sequence polymorphism in the σ1 neck. J Virol 1998;72:8205-8213.
88. Chappell JD, Duncan R, Mertens PPC, et al. Orthoreovirus, Reoviridae. In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, and Ball LA, eds. Virus Taxonomy: The Classification and Nomenclature of Viruses. The Eighth Report of the International Committee on Taxonomy of Viruses. London: Elsevier/Academic Press, 2005:455-465.
89. Chappell JD, Duong JL, Wright BW, et al. Identification of carbohydrate-binding domains in the attachment proteins of type 1 and type 3 reoviruses. J Virol 2000;74:8472-8479.
90. Chappell JD, Goral MI, Rodgers SE, et al. Sequence diversity within the reovirus S2 gene: reovirus genes reassort in nature, and their termini are predicted to form a panhandle motif. J Virol 1994;68:750-756.
91. Chappell JD, Gunn VL, Wetzel JD, et al. Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein σ1. J Virol 1997;71:1834-1841.
92. Chappell JD, Prota A, Dermody TS, et al. Crystal structure of reovirus attachment protein σ1 reveals evolutionary relationship to adenovirus fiber. EMBO J 2002;21:1-11.
93. Chen HT, Zhang J, Ma YP, et al. Reverse transcription loop-mediated isothermal amplification for the rapid detection of infectious bronchitis virus in infected chicken tissues. Mol Cell Probes 2010;24:104-106.
94. Chen WJ, Goldstein JL, Brown MS. NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. J Biol Chem 1990;265:3116-3123.
95. Chow N-L, Shatkin AJ. Blocked and unblocked 5' termini in reovirus genome RNA. J Virol 1975;15:1057-1064.
96. Chua K, Crameri G, Hyatt H, et al. A previously unknown reovirus of bat origin is associated with an acute respiratory disease in humans. Proc Natl Acad Sci U S A 2007;104:11424-11429.
97. Chua KB, Voon K, Crameri G, et al. Identification and characterization of a new orthoreovirus from patients with acute respiratory infections. PLoS One 2008;3:e3803.
98. Chua KB, Voon K, Yu M, et al. Investigation of a potential zoonotic transmission of orthoreovirus associated with acute influenza-like illness in an adult patient. PLoS One 2011;6:e25434.
99. Clark KM, Wetzel JD, Bayley J, et al. Reovirus variants selected for resistance to ammonium chloride have mutations in viral outer-capsid protein σ3. J Virol 2006;80:671-681.
100. Clarke P, Beckham JD, Leser JS, et al. Fas-mediated apoptotic signaling in the mouse brain following reovirus infection. J Virol 2009;83:6161-6170.
101. Clarke P, Debiasi RL, Meintzer SM, et al. Inhibition of NF-kappa B activity and cFLIP expression contribute to viral-induced apoptosis. Apoptosis 2005;10:513-524.
102. Clarke P, Meintzer SM, Gibson S, et al. Reovirus-induced apoptosis is mediated by TRAIL. J Virol 2000;74:8135-8139.
103. Clarke P, Meintzer SM, Moffitt LA, et al. Two distinct phases of virus-induced nuclear factor kappa B regulation enhance tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in virus-infected cells. J Biol Chem 2003;278:18092-18100.
104. Clarke P, Meintzer SM, Wang Y, et al. JNK regulates the release of proapoptotic mitochondrial factors in reovirus-infected cells. J Virol 2004;78:13132-13138.
105. Clarke P, Meintzer SM, Widmann C, et al. Reovirus infection activates JNK and the JNK-dependent transcription factor c-Jun. J Virol 2001;75: 11275-11283.
106. Cleveland DR, Zarbl H, Millward S. Reovirus guanyltransferase is L2 gene product lambda 2. J Virol 1986;60:307-311.
107. Coffey CM, Sheh A, Kim IS, et al. Reovirus outer capsid protein μ1 induces apoptosis and associates with lipid droplets, endoplasmic reticulum, and mitochondria. J Virol 2006;80:8422-8438.
108. Coffey MC, Strong JE, Forsyth PA, et al. Reovirus therapy of tumors with activated Ras pathway. Science 1998;282:1332-1334.
109. Compton T. Receptors and immune sensors: the complex entry path of human cytomegalovirus. Trends Cell Biol 2004;14:5-8.
110. Connolly JL, Barton ES, Dermody TS. Reovirus binding to cell surface sialic acid potentiates virus-induced apoptosis. J Virol 2001;75:4029-4039.
111. Connolly JL, Dermody TS. Virion disassembly is required for apoptosis induced by reovirus. J Virol 2002;76:1632-1641.
112. Connolly JL, Rodgers SE, Clarke P, et al. Reovirus-induced apoptosis requires activation of transcription factor NF-κB. J Virol 2000;74:2981-2989.
113. Coombs KM. Identification and characterization of a double-stranded RNA-reovirus temperature-sensitive mutant defective in minor core protein μ2. J Virol 1996;70:4237-4245.
114. Coombs KM. Stoichiometry of reovirus structural proteins in virus, ISVP, and core particles. Virology 1998;243:218-228.
115. Coombs KM, Mak SC, Petrycky-Cox LD. Studies of the major reovirus core protein sigma 2: reversion of the assembly-defective mutant tsC447 is an intragenic process and involves back mutation of Asp-383 to Asn. J Virol 1994;68:177-186.
116. Cox P, Griffith M, Angles M, et al. Concentrations of pathogens and indicators in animal feces in the Sydney watershed. Appl Environ Microbiol 2005;71:5929-5934.
117. Cuff CF, Cebra CK, Rubin DH, et al. Developmental relationship between cytotoxic alpha/beta T cell receptor-positive intraepithelial lymphocytes and Peyer's patch lymphocytes. Eur J Immunol 1993;23:1333-1339.
118. Dales S. Association between the spindle apparatus and reovirus. Proc Natl Acad Sci U S A 1963;50:268-275.
119. Dales S, Gomatos P, Hsu KC. The uptake and development of reovirus in strain L cells followed with labelled viral ribonucleic acid and ferritin-antibody conjugates. Virology 1965;25:193-211.
120. Danis C, Garzon S, Lemay G. Further characterization of the ts453 mutant of mammalian orthoreovirus serotype 3 and nucleotide sequence of the mutated S4 gene. Virology 1992;190:494-498.
121. Danthi P, Coffey CM, Parker JS, et al. Independent regulation of reovirus membrane penetration and apoptosis by the μ1 = domain. PLoS Pathog 2008;4:e1000248.
122. Danthi P, Hansberger MW, Campbell JA, et al. JAM-A-independent, antibody-mediated uptake of reovirus into cells leads to apoptosis. J Virol 2006;80:1261-1270.
123. Danthi P, Kobayashi T, Holm GH, et al. Reovirus apoptosis and virulence are regulated by host cell membrane-penetration efficiency. J Virol 2008;82:161-172.
124. Danthi P, Pruijssers AJ, Berger AK, et al. Bid regulates the pathogenesis of neurotropic reovirus. PLoS Pathog 2010;6:e1000980.
125. Davis CG, Lehrman MA, Russell DW, et al. The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors. Cell 1986;45:15-24.
126. Dawe A, Nuss D. Hypoviruses and chestnut blight: exploiting viruses to understand and modulate fungal pathogenesis. Annu Rev Genet 2001;35:1-29.
127. Day JM. The diversity of the orthoreoviruses: molecular taxonomy and phylogenetic divides. Infect Genet Evol 2009;9:390-400.
128. DeBiasi R, Edelstein C, Sherry B, et al. Calpain inhibition protects against virus-induced apoptotic myocardial injury. J Virol 2001;75:351-361.
129. DeBiasi RL, Clarke P, Meintzer SM, et al. Reovirus-induced alteration in expression of apoptosis and DNA repair genes with potential roles in viral pathogenesis. J Virol 2003;77:8934-8947.
130. DeBiasi RL, Robinson BA, Leser JS, et al. Critical role for death-receptor mediated apoptotic signaling in viral myocarditis. J Card Fail 2010;16: 901-910.
131. DeBiasi RL, Robinson BA, Sherry B, et al. Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo. J Virol 2004;78:11040-11050.
132. DeBiasi RL, Squier MKT, Pike B, et al. Reovirus-induced apoptosis is preceded by increased cellular calpain activity and is blocked by calpain inhibitors. J Virol 1999;73:695-701.
133. Decaro N, Campolo M, Desario C, et al. Virological and molecular characterization of a mammalian orthoreovirus type 3 strain isolated from a dog in Italy. Vet Microbiol 2005;109:19-27.
134. Demidenko AA, Nibert ML. Probing the transcription mechanisms of reovirus cores with molecules that alter RNA duplex stability. J Virol 2009;83:5659-5670.
135. Denzler KL, Jacobs BL. Site-directed mutagenic analysis of reovirus σ3 protein binding to dsRNA. Virology 1994;204:190-199.
136. Dermody TS. Molecular mechanisms of persistent infection by reovirus. Curr Top Microbiol Immunol 1998;233(Pt 2):1-22.
137. Dermody TS, Nibert ML, Bassel-Duby R, et al. Sequence diversity in S1 genes and S1 translation products of 11 serotype 3 reovirus strains. J Virol 1990;64:4842-4850.
138. Dermody TS, Nibert ML, Bassel-Duby R, et al. A σ1 region important for hemagglutination by serotype 3 reovirus strains. J Virol 1990;64:5173-5176.
139. Dermody TS, Nibert ML, Wetzel JD, et al. Cells and viruses with mutations affecting viral entry are selected during persistent infections of L cells with mammalian reoviruses. J Virol 1993;67:2055-2063.
140. Derrien M, Hooper JW, Fields BN. The M2 gene segment is involved in the capacity of reovirus type 3 Abney to induce the oily fur syndrome in neonatal mice, a S1 gene segment-associated phenotype. Virology 2003;305:25-30.
141. Detjen BM, Walden WE, Thach RE. Translational specificity in reovirus-infected mouse fibroblasts. J Biol Chem 1982;257:9855-9860.
142. Dhanasekaran DN, Reddy EP. JNK signaling in apoptosis. Oncogene 2008;27:6245-6251.
143. Dichter MA, Weiner HL. Infection of neuronal cell cultures with reovirus mimics in vitro patterns of neurotropism. Ann Neurol 1984;16:603-610.
144. Dionne KR, Galvin JM, Schittone SA, et al. Type I interferon signaling limits reoviral tropism within the brain and prevents lethal systemic infection. J Neurovirol 2011;17:314-326.
145. Donepudi M, Resh MD. c-Src trafficking and co-localization with the EGF receptor promotes EGF ligand-independent EGF receptor activation and signaling. Cell Signal 2008;20:1359-1367.
146. Douville RN, Su RC, Coombs KM, et al. Reovirus serotypes elicit distinctive patterns of recall immunity in humans. J Virol 2008;82:7515-7523.
147. Doyle JD, Danthi P, Kendall EA, et al. Molecular determinants of proteolytic disassembly of the reovirus outer capsid. J Biol Chem 2012;287:8029-8038.
148. Drayna D, Fields BN. Biochemical studies on the mechanism of chemical and physical inactivation of reovirus. J Gen Virol 1982;63:161-170.
149. Drayna D, Fields BN. Genetic studies on the mechanism of chemical and physical inactivation of reovirus. J Gen Virol 1982;63:149-160.
150. Dryden KA, Farsetta DL, Wang G, et al. Internal structures containing transcriptase-related proteins in top component particles of mammalian orthoreovirus. Virology 1998;245:33-46.
151. Dryden KA, Wang G, Yeager M, et al. Early steps in reovirus infection are associated with dramatic changes in supramolecular structure and protein conformation: analysis of virions and subviral particles by cryoelectron microscopy and image reconstruction. J Cell Biol 1993;122:1023-1041.
152. Duncan MR, Stanish SM, Cox DC. Differential sensitivity of normal and transformed human cells to reovirus infection. J Virol 1978;28:444-449.
153. Duncan R. Extensive sequence divergence and phylogenetic relationships between the fusogenic and nonfusogenic orthoreoviruses: a species proposal. Virology 1999;260:316-328.
154. Duncan R, Horne D, Cashdollar LW, et al. Identification of conserved domains in the cell attachment proteins of the three serotypes of reovirus. Virology 1990;174:399-409.
155. Dussaix E, Hadchouel M, Tardieu M, et al. Biliary atresia and reovirus type 3 infection [letter]. N Engl J Med 1984;310:658.
156. Ebert DH, Deussing J, Peters C, et al. Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J Biol Chem 2002;277: 24609-24617.
157. Ebert DH, Wetzel JD, Brumbaugh DE, et al. Adaptation of reovirus to growth in the presence of protease inhibitor E64 segregates with a mutation in the carboxy terminus of viral outer-capsid protein σ3. J Virol 2001;75:3197-3206.
158. Ehrlich M, Boll W, Van Oijen A, et al. Endocytosis by random initiation and stabilization of clathrin-coated pits. Cell 2004;118:591-605.
159. Epstein RL, Powers ML, Weiner HL. Interaction of reovirus with cell surface receptors. III. Reovirus type 3 induces capping of viral receptors on murine lymphocytes. J Immunol 1981;127:1800-1803.
160. Ernst H, Shatkin AJ. Reovirus hemagglutinin mRNA codes for two polypeptides in overlapping reading frames. Proc Natl Acad Sci U S A 1985;82:48-52.
161. Errington F, Steele L, Prestwich R, et al. Reovirus activates human dendritic cells to promote innate antitumor immunity. J Immunol 2008;180: 6018-6026.
162. Errington F, White CL, Twigger KR, et al. Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma. Gene Ther 2008;15:1257-1270.
163. Etoh T, Himeno Y, Matsumoto T, et al. Oncolytic viral therapy for human pancreatic cancer cells by reovirus. Clin Cancer Res 2003;9: 1218-1223.
164. Excoffon KJDA, Guglielmi KM, Wetzel JD, et al. Reovirus preferentially infects the basolateral surface and is released from the apical surface of polarized human respiratory epithelial cells. J Infect Dis 2008;197:1189-1197.
165. Fan JY, Boyce CS, Cuff CF. T-helper 1 and T-helper 2 cytokine responses in gut-associated lymphoid tissue following enteric reovirus infection. Cell Immunol 1998;188:55-63.
166. Farone AL, O'Donnell SM, Brooks CS, et al. Reovirus strain-dependent inflammatory cytokine responses and replication patterns in a human monocyte cell line. Viral Immunol 2006;19:546-557.
167. Farsetta DL, Chandran K, Nibert ML. Transcriptional activities of reovirus RNA polymerase in recoated cores: initiation and elongation are regulated by separate mechanisms. J Biol Chem 2000;275:39693-39701.
168. Fernandes J, Tang D, Leone G, et al. Binding of reovirus to receptor leads to conformational changes in viral capsid proteins that are reversible upon virus detachment. J Biol Chem 1994;269:17043-17047.
169. Fields BN, Joklik WK. Isolation and preliminary genetic and biochemical characterization of temperature-sensitive mutants of reovirus. Virology 1969;37:335-342.
170. Fields BN, Raine CS, Baum SG. Temperature-sensitive mutants of reovirus type 3: defects in viral maturation as studied by immunofluorescence and electron microscopy. Virology 1971;43:569-578.
171. Flamand A, Gagner JP, Morrison LA, et al. Penetration of the nervous systems of suckling mice by mammalian reoviruses. J Virol 1991;65:123-131.
172. Fleeton M, Contractor N, Leon F, et al. Peyer's patch dendritic cells process viral antigen from apoptotic epithelial cells in the intestine of reovirus-infected mice. J Exp Med 2004;200:235-245.
173. Forrest JC, Campbell JA, Schelling P, et al. Structure-function analysis of reovirus binding to junctional adhesion molecule 1: implications for the mechanism of reovirus attachment. J Biol Chem 2003;278:48434-48444.
174. Fraser RDB, Furlong DB, Trus BL, et al. Molecular structure of the cell-attachment protein of reovirus: correlation of computer-processed electron micrographs with sequence-based predictions. J Virol 1990;64: 2990-3000.
175. Fulton JR, Smith J, Cunningham C, et al. Influence of the route of infection on development of T-cell receptor beta-chain repertoires of reovirus-specific cytotoxic T lymphocytes. J Virol 2004;78:1582-1590.
176. Furlong DB, Nibert ML, Fields BN. Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J Virol 1988;62:246-256.
177. Furuichi Y, LaFiandra A, Shatkin AJ. 5'-Terminal structure and mRNA stability. Nature 1977;266:235-239.
178. Furuichi Y, Morgan M, Muthukrishnan S, et al. Reovirus messenger RNA contains a methylated blocked 5'-terminal structure M7G(5')ppp(5')GmpCp-. Proc Natl Acad Sci U S A 1975;72:362-366.
179. Furuichi Y, Muthukrishnan S, Shatkin AJ. 5'-Terminal M7G(5')ppp(5')Gmp in vivo: identification in reovirus genome RNA. Proc Natl Acad Sci U S A 1975;72:742-745.
180. Furuichi Y, Muthukrishnan S, Tomasz J, et al. Mechanism of formation of reovirus mRNA 5'-terminal blocked and methylated sequence M7 GpppGm pC. J Biol Chem 1976;251:5043-5053.
181. Gainey MD, Dillon PJ, Clark KM, et al. Paramyxovirus-induced shutoff of host and viral protein synthesis: role of the P and V proteins in limiting PKR activation. J Virol 2008;82:828-839.
182. Gampel A, Moss L, Jones MC, et al. VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endothelial storage compartment. Blood 2006;108:2624-2631.
183. Gentsch JR, Pacitti AF. Differential interaction of reovirus type 3 with sialylated receptor components on animal cells. Virology 1987;161:245-248.
184. Gentsch JR, Pacitti AF. Effect of neuraminidase treatment of cells and effect of soluble glycoproteins on type 3 reovirus attachment to murine L cells. J Virol 1985;56:356-364.
185. George A, Kost SI, Witzleben CL, et al. Reovirus-induced liver disease in severe combined immunodeficient (SCID) mice: a model for the study of viral infection, pathogenesis, and clearance. J Exp Med 1990;171:929-934.
186. Gillian AL, Schmechel SC, Livny J, et al. Reovirus protein σNS binds in multiple copies to single-stranded RNA and shares properties with single-stranded DNA binding proteins. J Virol 2000;74:5939-5948.
187. Gillies S, Bullivant S, Bellamy AR. Viral RNA polymerases: electron microscopy of reovirus reaction cores. Science 1971;174:694-696.
188. Gilmore R, Coffey MC, Lee PW. Active participation of Hsp90 in the biogenesis of the trimeric reovirus cell attachment protein σ1. J Biol Chem 1998;273:15227-15233.
189. Giordano MO, Martinez LC, Isa MB, et al. Twenty year study of the occurrence of reovirus infection in hospitalized children with acute gastroenteritis in Argentina. Pediatr Infect Dis J 2002;21:880-882.
190. Glaser JH, Balistreri WF, Morecki R. Role of reovirus type 3 in persistent infantile cholestasis. J Pediatr 1984;15:912-915.
191. Golden JW, Bahe JA, Lucas WT, et al. Cathepsin S supports acid-independent infection by some reoviruses. J Biol Chem 2004;279: 8547-8557.
192. Golden JW, Linke J, Schmechel S, et al. Addition of exogenous protease facilitates reovirus infection in many restrictive cells. J Virol 2002;76:7430-7443.
193. Golden JW, Schiff LA. Neutrophil elastase, an acid-independent serine protease, facilitates reovirus uncoating and infection in U937 promonocyte cells. Virol J 2005;2:48.
194. Gollamudi R, Ghalib MH, Desai KK, et al. Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors. Invest New Drugs 2009;28:641-649.
195. Gomatos PJ, Stoeckenius W. Electron microscope studies on reovirus RNA. Proc Natl Acad Sci U S A 1964;52:1449-1455.
196. Gomatos PJ, Tamm I. Macromolecular synthesis in reovirus-infected L cells. Biochim Biophys Acta 1963;72:651-653.
197. Gomatos PJ, Tamm I. The secondary structure of reovirus RNA. Proc Natl Acad Sci U S A 1963;49:707-714.
198. Gomatos PJ, Tamm I, Dales S, et al. Reovirus type 3: physical characteristics and interactions with L cells. Virology 1962;17:441-454.
199. Goody RJ, Beckham JD, Rubtsova K, et al. JAK-STAT signaling pathways are activated in the brain following reovirus infection. J Neurovirol 2007;13:373-383.
200. Goody RJ, Hoyt CC, Tyler KL. Reovirus infection of the CNS enhances iNOS expression in areas of virus-induced injury. Exp Neurol 2005;195:379-390.
201. Goody RJ, Schittone SA, Tyler KL. Experimental reovirus-induced acute flaccid paralysis and spinal motor neuron cell death. J Neuropathol Exp Neurol 2008;67:231-239.
202. Goral MI, Mochow-Grundy M, Dermody TS. Sequence diversity within the reovirus S3 gene: reoviruses evolve independently of host species, geographic locale, and date of isolation. Virology 1996;216:265-271.
203. Guardado CP, Fox GC, Hermo Parrado XL, et al. Structure of the carboxy-terminal receptor-binding domain of avian reovirus fibre σC. J Mol Biol 2005;354:137-149.
204. Guglielmi KM, Kirchner E, Holm GH, et al. Reovirus binding determinants in junctional adhesion molecule-A. J Biol Chem 2007;282:17930-17940.
205. Gupta SL, Holmes SL, Mehra LL. Interferon action against reovirus: activation of interferon induced protein kinase in mouse L 929 cells upon reovirus infection. Virology 1982;12:495-499.
206. Haller BL, Barkon ML, Li XY, et al. Brain- and intestine-specific variants of reovirus serotype 3 strain Dearing are selected during chronic infection of severe combined immunodeficient mice. J Virol 1995;69:3933-3937.
207. Haller BL, Barkon ML, Vogler GP, et al. Genetic mapping of reovirus virulence and organ tropism in severe combined immunodeficient mice: organ-specific virulence genes. J Virol 1995;69:357-364.
208. Halonen P. Growth, stability and hemagglutination of a reovirus. Ann Med Exp Biol Fenn 1961;39:132-142.
209. Hansberger MW, Campbell JA, Danthi P, et al. IκB kinase subunits α and γ are required for activation of NF-κB and induction of apoptosis by mammalian reovirus. J Virol 2007;81:1360-1371.
210. Harrington KJ, Vile RG, Melcher A, et al. Clinical trials with oncolytic reovirus: moving beyond phase I into combinations with standard therapeutics. Cytokine Growth Factor Rev 2010;21:91-98.
211. Harrison S. Principles of virus structure. In: Knipe DM, Howley PM, eds. Fields Virology. 4th ed. Philadelphia: Lippincott-Raven Press; 2001: 53-85.
212. Hashiro G, Loh PC, Yau JT. The preferential cytotoxicity of reovirus for certain transformed cell lines. Arch Virol 1977;54:307-315.
213. Hay AJ, Joklik WK. Demonstration that the same strand of reovirus genome RNA is transcribed in vitro and in vivo. Virology 1971;44: 450-453.
214. Hazelton PR, Coombs KM. The reovirus mutant tsA279 has temperature-sensitive lesions in the M2 and L2 genes: the M2 gene is associated with decreased viral protein production and blockade in transmembrane transport. Virology 1995;207:46-58.
215. Hazelton PR, Coombs KM. The reovirus mutant tsA279 L2 gene is associated with generation of a spikeless core particle: implications for capsid assembly. J Virol 1999;73:2298-2308.
216. Helander A, Miller CL, Myers KS, et al. Protective immunoglobulin A and G antibodies bind to overlapping intersubunit epitopes in the head domain of type 1 reovirus adhesin σ1. J Virol 2004;78:10695-10705.
217. Helander A, Silvey KJ, Mantis NJ, et al. The viral σ1 protein and glycoconjugates containing α2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces. J Virol 2003;77:7964-7977.
218. Hermann L, Embree J, Hazelton P, et al. Reovirus type 2 isolated from cerebrospinal fluid. Pediatr Infect Dis J 2004;23:373-375.
219. Hermann LL, Coombs KM. Inhibition of reovirus by mycophenolic acid is associated with the M1 genome segment. J Virol 2004;78:6171-6179.
220. Himeno Y, Etoh T, Matsumoto T, et al. Efficacy of oncolytic reovirus against liver metastasis from pancreatic cancer in immunocompetent models. Int J Oncol 2005;27:901-906.
221. Hingorani P, Zhang W, Lin J, et al. Systemic administration of reovirus (Reolysin) inhibits growth of human sarcoma xenografts. Cancer 2011;117:1764-1774.
222. Hirasawa K, Nishikawa SG, Norman KL, et al. Oncolytic reovirus against ovarian and colon cancer. Cancer Res 2002;62:1696-1701.
223. Hirasawa K, Nishikawa SG, Norman KL, et al. Systemic reovirus therapy of metastatic cancer in immune-competent mice. Cancer Res 2003;63:348-353.
224. Holm GH, Pruijssers AJ, Li L, et al. Interferon regulatory factor 3 attenuates reovirus myocarditis and contributes to viral clearance. J Virol 2010;84:6900-6908.
225. Holm GH, Zurney J, Tumilasci V, et al. Retinoic acid-inducible gene-I and interferon-β promoter stimulator-1 augment proapoptotic responses following mammalian reovirus infection via interferon regulatory factor-3. J Biol Chem 2007;282:21953-21961.
226. Hooper JW, Fields BN. Role of the μ1 protein in reovirus stability and capacity to cause chromium release from host cells. J Virol 1996;70: 459-467.
227. Hoyt CC, Richardson-Burns SM, Goody RJ, et al. Nonstructural protein σ1s is a determinant of reovirus virulence and influences the kinetics and severity of apoptosis induction in the heart and central nervous system. J Virol 2005;79:2743-2753.
228. Hrdy DB, Rubin DH, Fields BN. Molecular basis of reovirus neurovirulence: role of the M2 gene in avirulence. Proc Natl Acad Sci U S A 1982;79:1298-1302.
229. Huang I-C, Bosch BJ, Li F, et al. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J Biol Chem 2006;281:3198-3203.
230. Huang SM, Chen CC, Chiu PC, et al. Acute necrotizing encephalopathy of childhood associated with influenza type B virus infection in a 3-year-old girl. J Child Neurol 2004;19:64-67.
231. Huismans H, Joklik WK. Reovirus-coded polypeptides in infected cells: isolation of two native monomeric polypeptides with high affinity for single-stranded and double-stranded RNA, respectively. Virology 1976;70:411-424.
232. Hutchings AB, Helander A, Silvey KJ, et al. Secretory immunoglobulin A antibodies against the σ1 outer capsid protein of reovirus type 1 Lang prevent infection of mouse Peyer's patches. J Virol 2004;78:947-957.
233. Ikegami N, Gomatos PJ. Temperature-sensitive conditional-lethal mutants of reovirus 3. I. Isolation and characterization. Virology 1968;36: 447-458.
234. Imani F, Jacobs BL. Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 σ3 protein. Proc Natl Acad Sci U S A 1988;85:7887-7891.
235. Irvin SC, Zurney J, Ooms LS, et al. A single amino acid polymorphism in reovirus protein μ2 determines repression of interferon signaling and modulates myocarditis. J Virol 2012;86:2302-2311.
236. Ishii K, Ueda Y, Matsuo K, et al. Structural analysis of vaccinia virus DIs strain: application as a new replication-deficient viral vector. Virology 2002;302:433-444.
237. Ivanovic T, Agosto MA, Chandran K, et al. A role for molecular chaperone Hsc70 in reovirus outer-capsid disassembly. J Biol Chem 2007;282: 12210-12219.
238. Ivanovic T, Agosto MA, Zhang L, et al. Peptides released from reovirus outer capsid form membrane pores that recruit virus particles. EMBO J 2008;27:1289-1298.
239. Ivanovic T, Boulant S, Ehrlich M, et al. Recruitment of cellular clathrin to viral factories and disruption of clathrin-dependent trafficking. Traffic 2011;12:1179-1195.
240. Jackson GG, Muldoon RL. Viruses causing common respiratory infection in man. IV. Reoviruses and adenoviruses. J Infect Dis 1973;128: 811-833.
241. Jacobs BL, Atwater JA, Munemitsu SM, et al. Biosynthesis of reovirus-specified polypeptides: the S1 mRNA synthesized in vivo is structurally and functionally indistinguishable from in vitro-synthesized S1 mRNA and encodes two polypeptides, sigma 1a and sigma 1bNS. Virology 1985;147:9-18.
242. Jacobs BL, Ferguson RE. The Lang strain of reovirus serotype 1 and the Dearing strain of reovirus serotype 3 differ in their sensitivities to β interferon. J Virol 1991;65:5102-5104.
243. Jané-Valbuena J, Breun LA, Schiff LA, et al. Sites and determinants of early cleavages in the proteolytic processing pathway of reovirus surface protein σ3. J Virol 2002;76:5184-5197.
244. Jané-Valbuena J, Nibert ML, Spencer SM, et al. Reovirus virion-like particles obtained by recoating infectious subvirion particles with baculovirus-expressed σ3 protein: an approach for analyzing σ3 functions during virus entry. J Virol 1999;73:2963-2973.
245. Johansson C, Wetzel JD, Mikacenic C, et al. Type I interferons produced by hematopoietic cells protect mice against lethal infection by mammalian reovirus. J Exp Med 2007;204:1349-1358.
246. Johansson PJ, Sveger T, Ahlfors K, et al. Reovirus type 1 associated with meningitis. Scand J Infect Dis 1996;28:117-120.
247. Johnson EM, Doyle JD, Wetzel JD, et al. Genetic and pharmacologic alteration of cathepsin expression influences reovirus pathogenesis. J Virol 2009;83:9630-9640.
248. Joklik WK. Structure and function of the reovirus genome. Microbiol Rev 1981;45:483-501.
249. Jones RC. Avian reovirus infections. Rev Sci Tech 2000;19:614-625.
250. Kato H, Takeuchi O, Mikamo-Satoh E, et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008;205:1601-1610.
251. Kaufer S, Coffey CM, Parker JS. The cellular chaperone hsc70 is specifically recruited to reovirus viral factories independently of its chaperone function. J Virol 2012;86:1079-1089.
252. Kawaguchi K, Etoh T, Suzuki K, et al. Efficacy of oncolytic reovirus against human gastric cancer with peritoneal metastasis in experimental animal model. Int J Oncol 2010;37:1433-1438.
253. Kedl R, Schmechel S, Schiff L. Comparative sequence analysis of the reovirus S4 genes from 13 serotype 1 and serotype 3 field isolates. J Virol 1995;69:552-559.
254. Keroack M, Fields BN. Viral shedding and transmission between hosts determined by reovirus L2 gene. Science 1986;232:1635-1638.
255. Kilani RT, Tamimi Y, Hanel EG, et al. Selective reovirus killing of bladder cancer in a co-culture spheroid model. Virus Res 2003;93:1-12.
256. Kim J, Parker JS, Murray KE, et al. Nucleoside and RNA triphosphatase activities of orthoreovirus transcriptase cofactor μ2. J Biol Chem 2004;279:4394-4403.
257. Kim JW, Lyi SM, Parrish CR, et al. A proapoptotic peptide derived from reovirus outer capsid protein μ1 has membrane-destabilizing activity. J Virol 2011;85:1507-1516.
258. Kim M, Hansen KK, Davis L, et al. Z-FA-FMK as a novel potent inhibitor of reovirus pathogenesis and oncolysis in vivo. Antivir Ther 2010;15:897-905.
259. Kirchner E, Guglielmi KM, Strauss HM, et al. Structure of reovirus σ1 in complex with its receptor junctional adhesion molecule-A. PLoS Pathog 2008;4:e1000235.
260. Knowlton JJ, Dermody TS, Holm GH. Apoptosis induced by mammalian reovirus is interferon-beta-independent and enhanced by IRF-3- and NF-κB-dependent expression of Noxa. J Virol 2012;86: 1650-1660.
261. Kobayashi T, Antar AAR, Boehme KW, et al. A plasmid-based reverse genetics system for animal double-stranded RNA viruses. Cell Host Microbe 2007;1:147-157.
262. Kobayashi T, Chappell JD, Danthi P, et al. Gene-specific inhibition of reovirus replication by RNA interference. J Virol 2006;80:9053-9063.
263. Kobayashi T, Ooms LS, Chappell JD, et al. Identification of functional domains in reovirus replication proteins μNS and μ2. J Virol 2009;83:2892-2906.
264. Kobayashi T, Ooms LS, Ikizler M, et al. An improved reverse genetics system for mammalian orthoreoviruses. Virology 2010:194-200.
265. Kominsky DJ, Bickel RJ, Tyler KL. Reovirus-induced apoptosis requires both death receptor- and mitochondrial-mediated caspase-dependent pathways of cell death. Cell Death Differ 2002;9:926-933.
266. Kominsky DJ, Bickel RJ, Tyler KL. Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels. J Virol 2002;76:11414-11424.
267. Koonin EV. Evolution of double-stranded RNA viruses: a case for polyphyletic origin from different groups of positive-stranded RNA viruses. Semin Virol 1992;3:327-340.
268. Kozak M. Nucleotide sequences of 5'-terminal ribosome-protected initiation regions from two reovirus messages. Nature 1977;269:391-394.
269. Kozak M. Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6. EMBO J 1997;16:2482-2492.
270. Kozak M, Shatkin AJ. Characterization of ribosome-protected fragments from reovirus messenger RNA. J Biol Chem 1976;251:4259-4266.
271. Kozak M, Shatkin AJ. Identification of features in 5' terminal fragments from reovirus mRNA which are important for ribosome binding. Cell 1978;13:201-212.
272. Kuss SK, Best GT, Etheredge CA, et al. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 2011;334: 249-252.
273. Lai M-H, Werenne JJ, Joklik WK. The preparation of reovirus top component and its effect on host DNA and protein synthesis. Virology 1973;54:237-244.
274. Lai M-HT, Joklik WK. The induction of interferon by temperature-sensitive mutants of reovirus, UV-irradiated reovirus, and subviral reovirus particles. Virology 1973;51:191-204.
275. Laniosz V, Holthusen KA, Meneses PI. Bovine papillomavirus type 1: from clathrin to caveolin. J Virol 2008;82:6288-6298.
276. Lau RY, Van Alstyne D, Berckmans R, et al. Synthesis of reovirus-specific polypeptides in cells pretreated with cycloheximide. J Virol 1975;16:470-478.
277. Leary TP, Erker JC, Chalmers ML, et al. Detection of mammalian reovirus RNA by using reverse transcription-PCR: sequence diversity within the λ3-encoding L1 gene. J Clin Microbiol 2002;40:1368-1375.
278. Lee PWK, Hayes EC, Joklik WK. Characterization of anti-reovirus immunoglobulins secreted by cloned hybridoma cell lines. Virology 1981;108:134-146.
279. Lee PWK, Hayes EC, Joklik WK. Protein σ1 is the reovirus cell attachment protein. Virology 1981;108:156-163.
280. Leland MM, Hubbard GB, Sentmore HT, 3rd, et al. Outbreak of Orthoreovirus-induced meningoencephalomyelitis in baboons. Comp Med 2000;50:199-205.
281. Lemieux R, Lemay G, Millward S. The viral protein σ3 participates in translation of late viral mRNA in reovirus-infected L cells. J Virol 1987;61: 2472-2479.
282. Leone G, Coffey MC, Gilmore R, et al. C-terminal trimerization, but not N-terminal trimerization, of the reovirus cell attachment protein is a posttranslational and Hsp70/ATP-dependent process. J Biol Chem 1996;271:8466-8471.
283. Leone G, Mah DCW, Lee PWK. The incorporation of reovirus cell attachment protein σ1 into virions requires the amino-terminal hydrophobic tail and the adjacent heptad repeat region. Virology 1991;182:346-350.
284. Lerner AM, Cherry JD, Finland M. Haemagglutination with reoviruses. Virology 1963;19:58-65.
285. Lerner AM, Cherry JD, Klein JO, et al. Infections with reoviruses. N Engl J Med 1962;267:947-952.
286. Li JK-K, Keene JD, Scheible PP, et al. Nature of the 3'-terminal sequence of the plus and minus strands of the S1 gene of reovirus serotypes 1, 2, and 3. Virology 1980;105:41-51.
287. Li L, Sevinsky JR, Rowland MD, et al. Proteomic analysis reveals virus-specific Hsp25 modulation in cardiac myocytes. J Proteome Res 2010;9:2460-2471.
288. Li L, Sherry B. IFN-alpha expression and antiviral effects are subtype and cell type specific in the cardiac response to viral infection. Virology 2010;396:59-68.
289. Liemann S, Chandran K, Baker TS, et al. Structure of the reovirus membrane-penetration protein, μ1, in a complex with its protector protein, σ3. Cell 2002;108:283-295.
290. Lloyd RM, Shatkin AJ. Translational stimulation by reovirus polypeptide σ3: substitution for VA1-RNA and inhibition of phosphorylation of the α-subunit of eukaryotic initiation factor-II. J Virol 1992;66:6878-6884.
291. Loo YM, Fornek J, Crochet N, et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 2008;82:335-345.
292. Lopez AD, Avasarala S, Grewal S, et al. Differential role of the Fas/Fas ligand apoptotic pathway in inflammation and lung fibrosis associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia and acute respiratory distress syndrome. J Immunol 2009;183:8244-8257.
293. Lu X, McDonald SM, Tortorici MA, et al. Mechanism for coordinated RNA packaging and genome replication by rotavirus polymerase VP1. Structure 2008;16:1678-1688.
294. Lucia-Jandris P, Hooper JW, Fields BN. Reovirus M2 gene is associated with chromium release from mouse L cells. J Virol 1993;67:5339-5345.
295. Luongo CL, Contreras CM, Farsetta DL, et al. Binding site for S-adenosyl-L-methionine in a central region of mammalian orthoreovirus λ2 protein: evidence for activities in mRNA cap methylation. J Biol Chem 1998;273:23773-23780.
296. Luongo CL, Reinisch KM, Harrison SC, et al. Identification of the mRNA guanylyltransferase region and active site in reovirus λ2 protein. J Biol Chem 2000;275:2804-2810.
297. Maginnis MS, Forrest JC, Kopecky-Bromberg SA, et al. β1 integrin mediates internalization of mammalian reovirus. J Virol 2006;80:2760-2770.
298. Maginnis MS, Mainou BA, Derdowski AM, et al. NPXY motifs in the β1 integrin cytoplasmic tail are required for functional reovirus entry. J Virol 2008;82:3181-3191.
299. Mainou BA, Dermody TS. Src kinase mediates productive endocytic sorting of reovirus during cell entry. J Virol 2011;85:3203-3213.
300. Majeski EI, Harley RA, Bellum SC, et al. Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus Acute Respiratory Distress Syndrome. Am J Respir Cell Mol Biol 2003;28:208-217.
301. Majeski EI, Paintlia MK, Lopez AD, et al. Respiratory reovirus 1/L induction of intraluminal fibrosis, a model of bronchiolitis obliterans organizing pneumonia, is dependent on T lymphocytes. Am J Pathol 2003;163:1467-1479.
302. Major AS, Cuff CF. Effects of the route of infection on immunoglobulin G subclasses and specificity of the reovirus-specific humoral immune response. J Virol 1996;70:5968-5974.
303. Major AS, Cuff CF. Enhanced mucosal and systemic immune responses to intestinal reovirus infection in β2-microglobulin-deficient mice. J Virol 1997;71:5782-5789.
304. Mallo M, Martinez-Costas J, Benavente J. Avian reovirus S1133 can replicate in mouse L cells: effect of pH and cell attachment status on viral infection. J Virol 1991;65:5499-5505.
305. Mao ZX, Joklik WK. Isolation and enzymatic characterization of protein λ2, the reovirus guanylyltransferase. Virology 1991;185:377-386.
306. Maratos-Flier E, Goodman MJ, Murray AH, et al. Ammonium inhibits processing and cytotoxicity of reovirus, a nonenveloped virus. J Clin Invest 1986;78:1003-1007.
307. Marcato P, Shmulevitz M, Pan D, et al. Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release. Mol Ther 2007;15:1522-1530.
308. Marcotte R, Zhou LX, Kim H, et al. c-Src associates with ErbB2 through an interaction between catalytic domains and confers enhanced transforming potential. Mol Cell Biol 2009;29:5858-5871.
309. Martin-Padura I, Lostaglio S, Schneemann M, et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 1998;142:117-127.
310. Martinez CG, Guinea R, Benavente J, et al. The entry of reovirus into L cells is dependent on vacuolar proton-ATPase activity. J Virol 1996;70:576-579.
311. Mathers AR, Cuff CF. Role of interleukin-4 (IL-4) and IL-10 in serum immunoglobulin G antibody responses following mucosal or systemic reovirus infection. J Virol 2004;78:3352-3360.
312. Matoba Y, Colucci WS, Fields BN, et al. The reovirus M1 gene determines the relative capacity of growth of reovirus in cultured bovine aortic endothelial cells. J Clin Invest 1993;92:2883-2888.
313. Matoba Y, Sherry B, Fields BN, et al. Identification of the viral genes responsible for growth of strains of reovirus in cultured mouse heart cells. J Clin Invest 1991;87:1628-1633.
314. Matsuura K, Ishikura M, Nakayama T, et al. Ecological studies on reovirus pollution of rivers in Toyama Prefecture. II. Molecular epidemiological study of reoviruses isolated from river water. Microbiol Immunol 1993;37:305-310.
315. McCrae MA, Joklik WK. The nature of the polypeptide encoded by each of the ten double-stranded RNA segments of reovirus type 3. Virology 1978;89:578-593.
316. McCutcheon AM, Broering TJ, Nibert ML. Mammalian reovirus M3 gene sequences and conservation of coiled-coil motifs near the carboxyle terminus of the μNS protein. Virology 1999;264:16-24.
317. McDonald SM, Patton JT. Assortment and packaging of the segmented rotavirus genome. Trends Microbiol 2011;19:136-144.
318. McDonald SM, Tao YJ, Patton JT. The ins and outs of four-tunneled Reoviridae RNA-dependent RNA polymerases. Curr Opin Struct Biol 2009;19:775-782.
319. Mendez, II, Weiner SG, She YM, et al. Conformational changes accompany activation of reovirus RNA-dependent RNA transcription. J Struct Biol 2008;162:277-289.
320. Mendez II, She YM, Ens W, et al. Digestion pattern of reovirus outer capsid protein σ3 determined by mass spectrometry. Virology 2003;311: 289-304.
321. Merckel MC, Huiskonen JT, Bamford DH, et al. The structure of the bacteriophage PRD1 spike sheds light on the evolution of viral capsid architecture. Mol Cell 2005;18:161-170.
322. Mertens PPC, Duncan R, Attoui H, et al. Reoviridae. In: Fauquet CM, Mayo MA, Maniloff J, et al., eds. Virus Taxonomy: The Classification and Nomenclature of Viruses. The Eighth Report of the International Committee on Taxonomy of Viruses. London: Elsevier/Academic Press, 2005:447-454.
323. Metcalf P, Cyrklaff M, Adrian M. The 3-dimensional structure of reovirus obtained by cryoelectron microscopy. EMBO J 1991;10:3129-3136.
324. Middleton JK, Agosto MA, Severson TF, et al. Thermostabilizing mutations in reovirus outer-capsid protein μ1 selected by heat inactivation of infectious subvirion particles. Virology 2007;361:412-425.
325. Miller CL, Arnold MM, Broering TJ, et al. Localization of mammalian orthoreovirus proteins to cytoplasmic factory-like structures via nonoverlapping regions of μNS. J Virol 2010;84:867-882.
326. Miller CL, Broering TJ, Parker JS, et al. Reovirus σNS protein localizes to inclusions through an association requiring the μNS amino terminus. J Virol 2003;77:4566-4576.
327. Miller CL, Parker JS, Dinoso JB, et al. Increased ubiquitination and other covariant phenotypes attributed to a strain- and temperature-dependent defect of reovirus core protein μ2. J Virol 2004;78:10291-10302.
328. Miller JE, Samuel CE. Proteolytic cleavage of the reovirus σ3 protein results in enhanced double-stranded RNA-binding activity: identification of a repeated basic amino acid motif within the C-terminal binding region. J Virol 1992;66:5347-5356.
329. Milligan JF, Groebe DR, Witherell GW, et al. Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res 1987;15:8783-8798.
330. Millward S, Graham AF. Structural studies on reovirus: discontinuities in the genome. Proc Natl Acad Sci U S A 1970;65:422-426.
331. Minuk GY, Rascanin N, Paul RW, et al. Reovirus type 3 infection in patients with primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 1987;5:8-13.
332. Miura K, Watanabe K, Sugiura M, et al. The 5'-terminal nucleotide sequences of the double-stranded RNA of human reovirus. Proc Natl Acad Sci U S A 1974;71:3979-3983.
333. Miyamoto SD, Brown RD, Robinson BA, et al. Cardiac cell-specific apoptotic and cytokine responses to reovirus infection: determinants of myocarditic phenotype. J Card Fail 2009;15:529-539.
334. Mizuguchi M. Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan. Brain Dev 1997:81-92.
335. Mochizuki M, Uchizono S. Experimental infections of feline reovirus serotype 2 isolates. J Vet Med Sci 1993;55:4669-4670.
336. Mochow-Grundy M, Dermody TS. The reovirus S4 gene 3' nontranslated region contains a translational operator sequence. J Virol 2001;75: 6517-6526.
337. Morecki R, Glaser JH, Cho S, et al. Biliary atresia and reovirus type 3 infection. N Engl J Med 1982;307:481-484.
338. Morgan EM, Zweerink HJ. Characterization of transcriptase and replicase particles isolated from reovirus infected cells. Virology 1975;68: 455-466.
339. Morin MJ, Warner A, Fields BN. A pathway for entry of reoviruses into the host through M cells of the respiratory tract. J Exp Med 1994;180: 1523-1527.
340. Morin MJ, Warner A, Fields BN. Reovirus infection in rat lungs as a model to study the pathogenesis of viral pneumonia. J Virol 1996;70: 541-548.
341. Morris SM, Cooper JA. Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2. Traffic 2001;2:111-123.
342. Morrison LA, Sidman RL, Fields BN. Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers. Proc Natl Acad Sci U S A 1991;88:3852-3856.
343. Munemitsu SM, Atwater JA, Samuel CE. Biosynthesis of reovirus-specified polypeptides: molecular cDNA cloning and nucleotide sequence of the reovirus serotype 1 Lang strain bicistronic s1 mRNA which encodes the minor capsid polypeptide sigma 1a and the nonstructural polypeptide sigma 1bNS. Biochem Biophys Res Commun 1986;140:508-514.
344. Mustoe TA, Ramig RF, Sharpe AH, et al. A genetic map of reovirus. III. Assignment of the double-stranded RNA mutant groups A, B, and G to genome segments. Virology 1978;85:545-556.
345. Mustoe TA, Ramig RF, Sharpe AH, et al. Genetics of reovirus: identification of the dsRNA segments encoding the polypeptides of the μ and σ size classes. Virology 1978;89:594-604.
346. Muthukrishnan S, Both GW, Furuichi Y, et al. 5'-Terminal 7-methylguanosine in eukaryotic mRNA is required for translation. Nature 1975;255:33-37.
347. Muthukrishnan S, Shatkin AJ. Reovirus genome RNA segments: resistance to S-1 nuclease. Virology 1975;64:96-105.
348. Nibert ML. Rotavirus translation control protein takes RNA to heart. Structure 2002;10:129-130.
349. Nibert ML, Chappell JD, Dermody TS. Infectious subvirion particles of reovirus type 3 Dearing exhibit a loss in infectivity and contain a cleaved σ1 protein. J Virol 1995;69:5057-5067.
350. Nibert ML, Dermody TS, Fields BN. Structure of the reovirus cell-attachment protein: a model for the domain organization of σ1. J Virol 1990;64:2976-2989.
351. Nibert ML, Fields BN. A carboxy-terminal fragment of protein μ1/μ1C is present in infectious subvirion particles of mammalian reoviruses and is proposed to have a role in penetration. J Virol 1992;66:6408-6418.
352. Nibert ML, Margraf RL, Coombs KM. Nonrandom segregation of parental alleles in reovirus reassortants. J Virol 1996;70:7295-7300.
353. Nibert ML, Odegard AL, Agosto MA, et al. Putative autocleavage of reovirus μ1 protein in concert with outer-capsid disassembly and activation for membrane permeabilization. J Mol Biol 2005;345:461-474.
354. Nibert ML, Schiff LA, Fields BN. Mammalian reoviruses contain a myristoylated structural protein. J Virol 1991;65:1960-1967.
355. Nilsen TW, Maroney PA, Baglioni C. Inhibition of protein synthesis in reovirus-infected HeLa cells with elevated levels of interferon-induced protein kinase activity. J Biol Chem 1982;257:14593-14596.
356. Nilsen TW, Maroney PA, Baglioni C. Synthesis of (2'-5')oligoadenylate and activation of an endoribonuclease in interferon-treated HeLa cells infected with reovirus. J Virol 1982;42:1039-1045.
357. Noah DL, Blum MA, Sherry B. Interferon regulatory factor 3 is required for viral induction of beta interferon in primary cardiac myocyte cultures. J Virol 1999;73:10208-10213.
358. Nonoyama M, Graham AF. Appearance of defective virions in clones of reovirus. J Virol 1970;6:693-694.
359. Nonoyama M, Millward S, Graham AF. Control of transcription of the reovirus genome. Nucleic Acids Res 1974;1:373-385.
360. Nonoyama M, Watanabe Y, Graham AF. Defective virions of reovirus. J Virol 1970;6:226-236.
361. Norman KL, Coffey MC, Hirasawa K, et al. Reovirus oncolysis of human breast cancer. Hum Gene Ther 2002;13:641-652.
362. Nygaard R, Golden JW, Schiff LA. Impact of host proteases on reovirus infection in the respiratory tract. J Virol 2012;86:1238-1243.
363. O'Donnell SM, Hansberger MW, Connolly JL, et al. Organ-specific roles for transcription factor NF-κB in reovirus-induced apoptosis and disease. J Clin Invest 2005;115:2341-2350.
364. O'Donnell SM, Holm GH, Pierce JM, et al. Identification of an NF-κB-dependent gene network in cells infected by mammalian reovirus. J Virol 2006;80:1077-1086.
365. Oberhaus SM, Smith RL, Clayton GH, et al. Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. J Virol 1997;71:2100-2106.
366. Odegard AL, Chandran K, Zhang X, et al. Putative autocleavage of outer capsid protein μ1, allowing release of myristoylated peptide μ1N during particle uncoating, is critical for cell entry by reovirus. J Virol 2004;78:8732-8745.
367. Oleinikov AV, Zhao J, Makker SP. Cytosolic adaptor protein Dab2 is an intracellular ligand of endocytic receptor gp600/megalin. Biochem J 2000;347:613-621.
368. Olland AM, Jané-Valbuena J, Schiff LA, et al. Structure of the reovirus outer capsid and dsRNA-binding protein σ3 at 1.8 Å resolution. EMBO J 2001;20:979-989.
369. Ooms LS, Kobayashi T, Dermody TS, et al. A post-entry step in the mammalian orthoreovirus replication cycle is a determinant of cell tropism. J Biol Chem 2010;285:41604-41613.
370. Ouattara LA, Barin F, Barthez MA, et al. Novel human reovirus isolated from children with acute necrotizing encephalopathy. Emerging Infect Dis 2011;17:1436-1444.
371. Pal K, Kaetzel CS, Brundage K, et al. Regulation of polymeric immunoglobulin receptor expression by reovirus. J Gen Virol 2005;86:2347-2357.
372. Pan D, Pan LZ, Hill R, et al. Stabilisation of p53 enhances reovirus-induced apoptosis and virus spread through p53-dependent NF-κB activation. Br J Cancer 2011;105:1012-1022.
373. Parker JS, Broering TJ, Kim J, et al. Reovirus core protein μ2 determines the filamentous morphology of viral inclusion bodies by interacting with and stabilizing microtubules. J Virol 2002;76:4483-4496.
374. Paul-Murphy J, Work T, Hunter D, et al. Serologic survey and serum biochemical reference ranges of the free-ranging mountain lion (Felis concolor) in California. J Wildl Dis 1994;30:205-215.
375. Paul RW, Choi AH, Lee PWK. The α-anomeric form of sialic acid is the minimal receptor determinant recognized by reovirus. Virology 1989;172:382-385.
376. Paul RW, Lee PWK. Glycophorin is the reovirus receptor on human erythrocytes. Virology 1987;159:94-101.
377. Pichlmair A, Schulz O, Tan CP, et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006;314:997-1001.
378. Poggioli GJ, DeBiasi RL, Bickel R, et al. Reovirus-induced alterations in gene expression related to cell cycle regulation. J Virol 2002;76:2585-2594.
379. Poggioli GJ, Dermody TS, Tyler KL. Reovirus-induced σ1s-dependent G2/M cell cycle arrest results from inhibition of p34cdc2. J Virol 2001;75:7429-7434.
380. Poggioli GJ, Keefer CJ, Connolly JL, et al. Reovirus-induced G2/M cell cycle arrest requires σ1s and occurs in the absence of apoptosis. J Virol 2000;74:9562-9570.
381. Pritchard LI, Chua KB, Cummins D, et al. Pulau virus: a new member of the Nelson Bay orthoreovirus species isolated from fruit bats in Malaysia. Arch Virol 2006;151:229-239.
382. Prota AE, Campbell JA, Schelling P, et al. Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding. Proc Natl Acad Sci U S A 2003;100:5366-5371.
383. Qin Q, Carroll K, Hastings C, et al. Mammalian orthoreovirus escape from host translational shutoff correlates with stress granule disruption and is independent of eIF2alpha phosphorylation and PKR. J Virol 2011;85:8798-8810.
384. Qin QS, Hastings C, Miller CL. Mammalian orthoreovirus particles induce and are recruited into stress granules at early times postinfection. J Virol 2009;83:11090-11101.
385. Querbes W, O'Hara BA, Williams G, et al. Invasion of host cells by JC virus identifies a novel role for caveolae in endosomal sorting of noncaveolar ligands. J Virol 2006;80:9402-9413.
386. Racine T, Hurst T, Barry C, et al. Aquareovirus effects syncytiogenesis by using a novel member of the FAST protein family translated from a noncanonical translation start site. J Virol 2009;83:5951-5955.
387. Ramig RF, Ahmed R, Fields BN. A genetic map of reovirus: assignment of the newly defined mutant groups H, I, and J to genome segments. Virology 1983;125:299-313.
388. Ramig RF, Cross RK, Fields BN. Genome RNAs and polypeptides of reovirus serotypes 1, 2, and 3. J Virol 1977;22:726-733.
389. Ramig RF, Fields BN. Revertants of temperature-sensitive mutants of reovirus: evidence for frequent extragenic suppression. Virology 1979;92: 155-167.
390. Ramig RF, Mustoe TA, Sharpe AH, et al. A genetic map of reovirus. II. Assignment of the double-stranded RNA-negative mutant groups C, D, and E to genome segments. Virology 1978;85:531-534.
391. Ramig RF, White RM, Fields BN. Suppression of the temperature-sensitive phenotype of a mutant of reovirus type 3. Science 1977;195: 406-407.
392. Rankin UT, Jr., Eppes SB, Antczak JB, et al. Studies on the mechanism of the antiviral activity of ribavirin against reovirus. Virology 1989;168: 147-158.
393. Rauschenfels S, Krassmann M, Al-Masri AN, et al. Incidence of hepatotropic viruses in biliary atresia. Eur J Pediatr 2009;168:469-476.
394. Reinisch KM, Nibert ML, Harrison SC. Structure of the reovirus core at 3.6 Å resolution. Nature 2000;404:960-967.
395. Reiter DM, Frierson JM, Halvorson EE, et al. Crystal structure of reovirus attachment protein σ1 in complex with sialylated oligosaccharides. PLoS Pathog 2011;7:e1002166.
396. Richardson-Burns SM, Kominsky DJ, Tyler KL. Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors. J Neurovirol 2002;8:365-380.
397. Richardson-Burns SM, Tyler KL. Minocycline delays disease onset and mortality in reovirus encephalitis. Exp Neurol 2005;192:331-339.
398. Richardson-Burns SM, Tyler KL. Regional differences in viral growth and central nervous system injury correlate with apoptosis. J Virol 2004;78:5466-5475.
399. Richardson SC, Bishop RF, Smith AL. Enzyme-linked immunosorbent assays for measurement of reovirus immunoglobulin G, A, and M levels in serum. J Clin Microbiol 1988;26:1871-1873.
400. Richardson SC, Bishop RF, Smith AL. Reovirus serotype 3 infection in infants with extrahepatic biliary atresia or neonatal hepatitis. J Gastroenterol Hepatol 1994;9:264-268.
401. Riese RJ, Wolf PR, Bromme D, et al. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996;4:357-366.
402. Robertson CM, Hermann LL, Coombs KM. Mycophenolic acid inhibits avian reovirus replication. Antiviral Res 2004;64:55-61.
403. Rodgers SE, Barton ES, Oberhaus SM, et al. Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2. J Virol 1997;71:2540-2546.
404. Rodgers SE, Connolly JL, Chappell JD, et al. Reovirus growth in cell culture does not require the full complement of viral proteins: identification of a σ1s-null mutant. J Virol 1998;72:8597-8604.
405. Roner MR, Bassett K, Roehr J. Identification of the 5' sequences required for incorporation of an engineered ssRNA into the reovirus genome. Virology 2004;329:348-360.
406. Roner MR, Gaillard RK, Joklik WK. Control of reovirus messenger RNA translation efficiency by the regions upstream of initiation codons. Virology 1989;168:292-301.
407. Roner MR, Joklik WK. Reovirus reverse genetics: incorporation of the CAT gene into the reovirus genome. Proc Natl Acad Sci U S A 2001;98:8036-8041.
408. Roner MR, Roehr J. The 3' sequences required for incorporation of an engineered ssRNA into the Reovirus genome. Virol J 2006;3:1.
409. Roner MR, Steele BG. Localizing the reovirus packaging signals using an engineered m1 and s2 ssRNA. Virology 2007;358:89-97.
410. Roner MR, Sutphin LA, Joklik WK. Reovirus RNA is infectious. Virology 1990;179:845-852.
411. Rosen L. Reoviruses in animals other than man. Ann NY Acad Sci 1962;101:461-465.
412. Rosen L. Serologic grouping of reovirus by hemagglutination-inhibition. Am J Hyg 1960;71:242-249.
413. Rosen L, Abinanti FR. Natural and experimental infection of cattle with human types of reovirus. Am J Hyg 1960;71:424-429.
414. Rosen L, Abinanti FR, Hovis JF. Further observations on the natural infection of cattle with reoviruses. Am J Hyg 1963;77:38-48.
415. Rosen L, Evans HE, Spickard A. Reovirus infections in human volunteers. Am J Hyg 1963;77:29-37.
416. Rosen L, Hovis JF, Mastrota FM, et al. An outbreak of infection with a type 1 reovirus among children in an institution. Am J Hyg 1960;71:266-274.
417. Rosen L, Hovis JF, Mastrota FM, et al. Observations on a newly recognized virus (Abney) of the reovirus family. Am J Hyg 1960;71:258-265.
418. Rubin DH. Reovirus serotype 1 binds to the basolateral membrane of intestinal epithelial cells. Microb Pathog 1987;3:215-220.
419. Rubin DH, Fields BN. Molecular basis of reovirus virulence: role of the M2 gene. J Exp Med 1980;152:853-868.
420. Rubin DH, Kornstein MJ, Anderson AO. Reovirus serotype 1 intestinal infection: a novel replicative cycle with ileal disease. J Virol 1985;53: 391-398.
421. Rubin DH, Weiner DB, Dworkin C, et al. Receptor utilization by reovirus type 3: distinct binding sites on thymoma and fibroblast cell lines result in differential compartmentalization of virions. Microb Pathog 1992;12:351-365.
422. Rubin DH, Wetzel JD, Williams WV, et al. Binding of type 3 reovirus by a domain of the σ1 protein important for hemagglutination leads to infection of murine erythroleukemia cells. J Clin Invest 1992;90:2536-2542.
423. Sabin AB. Reoviruses: a new group of respiratory and enteric viruses formerly classified as ECHO type 10 is described. Science 1959;130: 1387-1389.
424. Saito T, Shinozaki K, Matsunaga T, et al. Lack of evidence for reovirus infection in tissues from patients with biliary atresia and congenital dilatation of the bile duct. J Hepatol 2004;40:203-211.
425. Sakuma S, Watanabe Y. Incorporation of in vitro synthesized reovirus double-stranded ribonucleic acid into virus corelike particles. J Virol 1972;10:943-950.
426. Salsman J, Top D, Boutilier J, et al. Extensive syncytium formation mediated by the reovirus FAST proteins triggers apoptosis-induced membrane instability. J Virol 2005;79:8090-8100.
427. Sandilands E, Cans C, Fincham VJ, et al. RhoB and actin polymerization coordinate Src activation with endosome-mediated delivery to the membrane. Dev Cell 2004;7:855-869.
428. Saragovi HU, Rebai N, Di Guglielmo GM, et al. A G1 cell cycle arrest induced by ligands of the reovirus type 3 receptor is secondary to inactivation of p21ras and mitogen-activated protein kinase. DNA Cell Biol 1999;18:763-770.
429. Sarkar G, Pelletier J, Bassel-Duby R, et al. Identification of a new polypeptide coded by reovirus gene S1. J Virol 1985;54:720-725.
430. Sarkar P, Danthi P. Determinants of strain-specific differences in efficiency of reovirus entry. J Virol 2010;84:12723-12732.
431. Schelling P, Guglielmi KM, Kirchner E, et al. The reovirus σ1 aspartic acid sandwich: a trimerization motif poised for conformational change. J Biol Chem 2007;282:11582-11589.
432. Schiff LA, Nibert ML, Co MS, et al. Distinct binding sites for zinc and double-stranded RNA in the reovirus outer capsid protein σ3. Mol Cell Biol 1988;8:273-283.
433. Schmechel S, Chute M, Skinner P, et al. Preferential translation of reovirus mRNA by a σ3-dependent mechanism. Virology 1997;232:62-73.
434. Schuerch AR, Matshuhisa I, Joklik WK. Temperature-sensitive mutants of reovirus. VI. Mutants ts447 and ts556 particles lack one or two L genome RNA segments. Intervirology 1974;3:36-46.
435. Scott FW, Kahn DE, Gillespie JH. Feline reovirus: isolation, characterization, and pathogenicity of a feline reovirus. Am J Vet Res 1970;31: 11-20.
436. Sei S, Mussio JK, Yang QE, et al. Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells. Mol Cancer 2009;8:47.
437. Selb B, Weber B. A study of human reovirus IgG and IgA antibodies by ELISA and western blot. J Virol Methods 1994;47:15-25.
438. Seliger LS, Zheng K, Shatkin AJ. Complete nucleotide sequence of reovirus L2 gene and deduced amino acid sequence of viral mRNA guanylyltransferase. J Biol Chem 1987;262:16289-16293.
439. Sharpe AH, Fields BN. Reovirus inhibition of cellular DNA synthesis: role of the S1 gene. J Virol 1981;38:389-392.
440. Sharpe AH, Fields BN. Reovirus inhibition of cellular RNA and protein synthesis: role of the S4 gene. Virology 1982;122:381-391.
441. Sharpe AH, Ramig RF, Mustoe TA, et al. A genetic map of reovirus. I. Correlation of genome RNAs between serotypes 1, 2, and 3. Virology 1978;84:63-74.
442. Shatkin AJ, LaFiandra AJ. Transcription by infectious subviral particles of reovirus. J Virol 1972;10:698-706.
443. Shatkin AJ, Sipe JD. Single-stranded adenine-rich RNA from purified reoviruses. Proc Natl Acad Sci U S A 1968;59:246-253.
444. Shatkin AJ, Sipe JD, Loh PC. Separation of 10 reovirus genome segments by polyacrylamide gel electrophoresis. J Virol 1968;12:986-991.
445. Shaw JE, Cox DC. Early inhibition of cellular DNA synthesis by high multiplicities of infectious and UV-irradiated reovirus. J Virol 1973;12:704-710.
446. Shepard DA, Ehnstrom JG, Schiff LA. Association of reovirus outer capsid proteins σ3 and μ1 causes a conformational change that renders σ3 protease sensitive. J Virol 1995;69:8180-8184.
447. Shepard DA, Ehnstrom JG, Skinner PJ, et al. Mutations in the zinc-binding motif of the reovirus capsid protein σ3 eliminate its ability to associate with capsid protein μ1. J Virol 1996;70:2065-2068.
448. Sherry B, Blum MA. Multiple viral core proteins are determinants of reovirus-induced acute myocarditis. J Virol 1994;68:8461-8465.
449. Sherry B, Fields BN. The reovirus M1 gene, encoding a viral core protein, is associated with the myocarditic phenotype of a reovirus variant. J Virol 1989;63:4850-4856.
450. Sherry B, Li XY, Tyler KL, et al. Lymphocytes protect against and are not required for reovirus-induced myocarditis. J Virol 1993;67:6119-6124.
451. Sherry B, Schoen FJ, Wenske E, et al. Derivation and characterization of an efficiently myocarditic reovirus variant. J Virol 1989;63:4840-4849.
452. Sherry B, Torres J, Blum MA. Reovirus induction of and sensitivity to beta interferon in cardiac myocyte cultures correlate with induction of myocarditis and are determined by viral core proteins. J Virol 1998;72:1314-1323.
453. Shmulevitz M, Duncan R. A new class of fusion-associated small transmembrane (FAST) proteins encoded by the non-enveloped fusogenic reoviruses. EMBO J 2000;19:902-912.
454. Shmulevitz M, Pan LZ, Garant K, et al. Oncogenic Ras promotes reovirus spread by suppressing IFN-β production through negative regulation of RIG-I signaling Cancer Res 2010;70:4912-4921.
455. Silverstein SC, Astell C, Christman J, et al. Synthesis of reovirus oligoadenylic acid in vivo and in vitro. J Virol 1974;13:740-752.
456. Silverstein SC, Astell C, Levin DH, et al. The mechanism of reovirus uncoating and gene activation in vivo. Virology 1972;47:797-806.
457. Silvey KJ, Hutchings AB, Vajdy M, et al. Role of immunoglobulin A in protection against reovirus entry into murine Peyer's patches. J Virol 2001;75:10870-10879.
458. Skehel JJ, Joklik WK. Studies on the in vitro transcription of reovirus RNA catalyzed by reovirus cores. Virology 1969;39:822-831.
459. Skup D, Millward S. mRNA capping enzymes are masked in reovirus progeny subviral particles. J Virol 1980;34:490-496.
460. Skup D, Millward S. Reovirus-induced modification of cap dependent translation in infected L cells. Proc Natl Acad Sci U S A 1980;77:152-156.
461. Smith JA, Schmechel SC, Raghavan A, et al. Reovirus induces and benefits from an integrated cellular stress response. J Virol 2006;80:2019-2033.
462. Smith JA, Schmechel SC, Williams BR, et al. Involvement of the interferon-regulated antiviral proteins PKR and RNase L in reovirus-induced shutoff of cellular translation. J Virol 2005;79:2240-2250.
463. Smith RE, Zweerink HJ, Joklik WK. Polypeptide components of virions, top component and cores of reovirus type 3. Virology 1969;39:791-810.
464. Song L, Ohnuma T, Gelman IH, et al. Reovirus infection of cancer cells is not due to activated Ras pathway. Cancer Gene Ther 2009;16:382.
465. Spear PG. Viral interactions with receptors in cell junctions and effects on junctional stability. Dev Cell 2002;3:462-464.
466. Spendlove RS, Lennette EH, Knight CO, et al. Production in FL cells of infectious and potentially infectious reovirus. J Bacteriol 1966;92:1036-1040.
467. Spriggs DR, Bronson RT, Fields BN. Hemagglutinin variants of reovirus type 3 have altered central nervous system tropism. Science 1983;220: 505-507.
468. Spriggs DR, Fields BN. Attenuated reovirus type 3 strains generated by selection of haemagglutinin antigenic variants. Nature 1982;297:68-70.
469. Spriggs DR, Kaye K, Fields BN. Topological analysis of the reovirus type 3 hemagglutinin. Virology 1983;127:220-224.
470. Starnes MC, Joklik WK. Reovirus protein λ3 is a poly(C)-dependent poly(G) polymerase. Virology 1993;193:356-366.
471. Steele MI, Marshall CM, Lloyd RE, et al. Reovirus 3 not detected by reverse transcriptase-mediated polymerase chain reaction analysis of preserved tissue from infants with cholestatic liver disease. Hepatology 1995;21:697-702.
472. Stehle T, Dermody TS. Structural evidence for common functions and ancestry of the reovirus and adenovirus attachment proteins. Rev Med Virol 2003;13:123-132.
473. Stewart MJ, Blum MA, Sherry B. PKR's protective role in viral myocarditis. Virology 2003;314:92-100.
474. Stewart MJ, Smoak K, Blum MA, et al. Basal and reovirus-induced beta interferon (IFN-β) and IFN-β-stimulated gene expression are cell type specific in the cardiac protective response. J Virol 2005;79:2979-2987.
475. Stoeckel J, Hay JG. Drug evaluation: Reolysin-wild-type reovirus as a cancer therapeutic. Curr Opin Mol Ther 2006;8:249-260.
476. Strong JE, Coffey MC, Tang D, et al. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J 1998;17:3351-3362.
477. Strong JE, Lee PW. The v-erbB oncogene confers enhanced cellular susceptibility to reovirus infection. J Virol 1996;70:612-616.
478. Strong JE, Leone G, Duncan R, et al. Biochemical and biophysical characterization of the reovirus cell attachment protein sigma 1: evidence that it is a homotrimer. Virology 1991;184:23-32.
479. Strong JE, Tang D, Lee PWK. Evidence that the epidermal growth factor receptor on host cells confers reovirus infection efficiency. Virology 1993;197:405-411.
480. Sturzenbecker LJ, Nibert ML, Furlong DB, et al. Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J Virol 1987;61:2351-2361.
481. Sun SC. Non-canonical NF-κB signaling pathway. Cell Res 2011;21:71-85.
482. Tai JH, Williams JV, Edwards KM, et al. Prevalence of reovirus-specific antibodies in young children in Nashville, Tennessee. J Infect Dis 2005;191:1221-1224.
483. Tao Y, Farsetta DL, Nibert ML, et al. RNA synthesis in a cage: structural studies of reovirus polymerase λ3. Cell 2002;111:733-745.
484. Tardieu M, Weiner HL. Viral receptors on isolated murine and human ependymal cells. Science 1982;215:419-421.
485. Taterka J, Cebra JJ, Rubin DH. Characterization of cytotoxic cells from reovirus-infected SCID mice: activated cells express natural killer- and lymphokine-activated killer-like activity but fail to clear infection. J Virol 1995;69:3910-3914.
486. Terheggen F, Benedikz E, Frissen PHJ, et al. Myocarditis associated with reovirus infection. Eur J Clin Microbiol Infect Dis 2003;22:197-198.
487. Thalmann CM, Cummins DM, Yu M, et al. Broome virus, a new fusogenic Orthoreovirus species isolated from an Australian fruit bat. Virology 2010;402:26-40.
488. Thirukkumaran CM, Luider JM, Stewart DA, et al. Biological purging of breast cancer cell lines using a replication-competent oncolytic virus in human stem cell autografts. Bone Marrow Transplant 2005;35:1055-1064.
489. Thirukkumaran CM, Luider JM, Stewart DA, et al. Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation. Blood 2003;102:377-387.
490. Thirukkumaran CM, Nodwell MJ, Hirasawa K, et al. Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeutic. Cancer Res 2010;70:2435-2444.
491. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997;13:513-609.
492. Tosteson MT, Nibert ML, Fields BN. Ion channels induced in lipid bilayers by subvirion particles of the nonenveloped mammalian reoviruses. Proc Natl Acad Sci U S A 1993;90:10549-10552.
493. Twigger K, Vidal L, White CL, et al. Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy. Clin Cancer Res 2008;14:912-923.
494. Tyler KL, Barton ES, Ibach ML, et al. Isolation and molecular characterization of a novel type 3 reovirus from a child with meningitis. J Infect Dis 2004;189:1664-1675.
495. Tyler KL, Fields BN. Reoviridae: the reoviruses. In: Murphy FA, eds. Laboratory Diagnosis of Infectious Disease: Principles and Practice (vol II) Viral, Rickettsial and Chlamydial Diseases. New York: Springer-Verlag, 1988: 353-374.
496. Tyler KL, Leser JS, Phang TL, et al. Gene expression in the brain during reovirus encephalitis. J Neurovirol 2010;16:56-71.
497. Tyler KL, Mann MA, Fields BN, et al. Protective anti-reovirus monoclonal antbodies and their effects on viral pathogenesis. J Virol 1993;67: 3446-3453.
498. Tyler KL, McPhee DA, Fields BN. Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science 1986;233:770-774.
499. Tyler KL, Sokol RJ, Oberhaus SM, et al. Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts. Hepatology 1998;27:1475-1482.
500. Tyler KL, Squier MK, Rodgers SE, et al. Differences in the capacity of reovirus strains to induce apoptosis are determined by the viral attachment protein σ1. J Virol 1995;69:6972-6979.
501. Tyler KL, Squier MKT, Brown AL, et al. Linkage between reovirus-induced apoptosis and inhibition of cellular DNA synthesis: role of the S1 and M2 genes. J Virol 1996;70:7984-7991.
502. Tyler KL, Virgin HW, Bassel-Duby R, et al. Antibody inhibits defined stages in the pathogenesis of reovirus serotype 3 infection of the central nervous system. J Exp Med 1989;170:887-900.
503. Ugolini S, Mondor I, Sattentau QJ. HIV-1 attachment: another look. Trends Microbiol 1999;7:144-149.
504. van Houdt WJ, Smakman N, van den Wollenberg DJ, et al. Transient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles. Cancer Gene Ther 2008;15:284-292.
505. van Raaij MJ, Mitraki A, Lavigne G, et al. A triple β-spiral in the adenovirus fibre shaft reveals a new structural motif for a fibrous protein. Nature 1999;401:935-938.
506. Vedula SR, Lim TS, Kirchner E, et al. A comparative molecular force spectroscopy study of homophilic JAM-A interactions and JAM-A interactions with reovirus attachment protein σ1. J Mol Recognit 2008;21:210-216.
507. Vidal L, Pandha HS, Yap TA, et al. A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer. Clin Cancer Res 2008;14:7127-7137.
508. Virgin HW, IV, Bassel-Duby R, Fields BN, et al. Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J Virol 1988;62:4594-4604.
509. Virgin HW, Tyler KL. Role of immune cells in protection against and control of reovirus infection in neonatal mice. J Virol 1991;65:5157-5164.
510. Virgin HW, Tyler KL, Dermody TS. Reovirus. In: Nathanson N, eds. Viral Pathogenesis. New York: Lippincott-Raven, 1997:669-699.
511. Wang Q, Bergeron J, Mabrouk T, et al. Site-directed mutagenesis of the double-stranded RNA binding domain of bacterially-expressed sigma 3 reovirus protein. Virus Res 1996;41:141-151.
512. Watanabe Y, Millward S, Graham AF. Regulation of transcription of the reovirus genome. J Mol Biol 1968;36:107-123.
513. Watanabe Y, Prevec L, Graham AF. Specificity in transcription of the reovirus genome. Proc Natl Acad Sci U S A 1967;58:1040-1047.
514. Weiner HL, Ault KA, Fields BN. Interaction of reovirus with cell surface receptors. I. Murine and human lymphocytes have a receptor for the hemagglutinin of reovirus type 3. J Immunol 1980;124:2143-2148.
515. Weiner HL, Drayna D, Averill DR, Jr, et al. Molecular basis of reovirus virulence: role of the S1 gene. Proc Natl Acad Sci U S A 1977;74:5744-5748.
516. Weiner HL, Fields BN. Neutralization of reovirus: the gene responsible for the neutralization antigen. J Exp Med 1977;146:1305-1310.
517. Weiner HL, Powers ML, Fields BN. Absolute linkage of virulence and central nervous system tropism of reoviruses to viral hemagglutinin. J Infect Dis 1980;141:609-616.
518. Weiner HL, Ramig RF, Mustoe TA, et al. Identification of the gene coding for the hemagglutinin of reovirus. Virology 1978;86:581-584.
519. Wellehan JFX, Childress AL, Marschang RE, et al. Consensus nested PCR amplification and sequencing of diverse reptilian, avian, and mammalian orthoreoviruses. Vet Microbiol 2009;133:34-42.
520. Wells SE, Hillner PE, Vale RD, et al. Circularization of mRNA by eukaryotic translation initiation factors. Mol Cell 1998;2:135-140.
521. Wenske EA, Chanock SJ, Krata L, et al. Genetic reassortment of mammalian reoviruses in mice. J Virol 1985;56:613-616.
522. Wessner DR, Fields BN. Isolation and genetic characterization of ethanol-resistant reovirus mutants. J Virol 1993;67:2442-2447.
523. Wetzel JD, Barton ES, Chappell JD, et al. Reovirus delays diabetes onset but does not prevent insulitis in non-obese diabetic mice. J Virol 2006;80:3078-3082.
524. Wetzel JD, Wilson GJ, Baer GS, et al. Reovirus variants selected during persistent infections of L cells contain mutations in the viral S1 and S4 genes and are altered in viral disassembly. J Virol 1997;71:1362-1369.
525. Wiener JR, Bartlett JA, Joklik WK. The sequences of reovirus serotype 3 genome segments M1 and M3 encoding the minor protein μ2 and the major nonstructural protein μNS, respectively. Virology 1989;169: 293-304.
526. Wiener JR, Joklik WK. Comparison of the reovirus serotype 1, 2, and 3 S3 genome segments encoding the nonstructural protein σNS. Virology 1987;161:332-339.
527. Wiener JR, McLaughlin T, Joklik WK. The sequence of the S2 genome segment of reovirus serotype 3 and of that of the dsRNA-negative mutant ts447. Virology 1989;170:340-341.
528. Wilcox ME, Yang W, Senger D, et al. Reovirus as an oncolytic agent against experimental human malignant gliomas. J Natl Cancer Inst 2001;93:903-912.
529. Williams LA, Martin-Padura I, Dejana E, et al. Identification and characterisation of human junctional adhesion molecule (JAM). Mol Immunol 1999;36:1175-1188.
530. Wilson GA, Morrison LA, Fields BN. Association of the reovirus S1 gene with serotype 3-induced biliary atresia in mice. J Virol 1994;68: 6458-6465.
531. Wilson GJ, Nason EL, Hardy CS, et al. A single mutation in the carboxy terminus of reovirus outer-capsid protein σ3 confers enhanced kinetics of σ3 proteolysis, resistance to inhibitors of viral disassembly, and alterations in σ3 structure. J Virol 2002;76:9832-9843.
532. Wilson GJ, Wetzel JD, Puryear W, et al. Persistent reovirus infections of L cells select mutations in viral attachment protein σ1 that alter oligomer stability. J Virol 1996;70:6598-6606.
533. Wisniewski ML, Werner BG, Hom LG, et al. Reovirus infection or ectopic expression of outer capsid protein μ1 induces apoptosis independently of the cellular proapoptotic proteins Bax and Bak. J Virol 2011;85:296-304.
534. Wolf JL, Rubin DH, Finberg R, et al. Intestinal M cells: a pathway of entry of reovirus into the host. Science 1981;212:471-472.
535. Xu P, Miller SE, Joklik WK. Generation of reovirus core-like particles in cells infected with hybrid vaccinia viruses that express genome segments L1, L2, L3, and S2. Virology 1993;197:726-731.
536. Yamakawa M, Furuichi Y, Nakashima K, et al. Excess synthesis of viral mRNA 5'-terminal oligonucleotides by reovirus transcriptase. J Biol Chem 1981;256:6507-6514.
537. Yan XD, Parent KN, Goodman RP, et al. Virion structure of baboon reovirus, a fusogenic orthoreovirus that lacks an adhesion fiber. J Virol 2011;85:7483-7495.
538. Yang WQ, Senger D, Muzik H, et al. Reovirus prolongs survival and reduces the frequency of spinal and leptomeningeal metastases from medulloblastoma. Cancer Res 2003;63:3162-3172.
539. Yao K, Vakharia VN. Generation of infectious pancreatic necrosis virus from cloned cDNA. J Virol 1998;72:8913-8920.
540. Yin P, Cheang M, Coombs KM. The M1 gene is associated with differences in the temperature optimum of the transcriptase activity in reovirus core particles. J Virol 1996;70:1223-1227.
541. Yin P, Keirstead ND, Broering TJ, et al. Comparisons of the M1 genome segments and encoded μ2 proteins of different reovirus isolates. Virol J 2004;1:6.
542. Young JC, Agashe VR, Siegers K, et al. Pathways of chaperone-mediated protein folding in the cytosol. Nat Rev Mol Cell Biol 2004;5:781-791.
543. Yue Z, Shatkin AJ. Double-stranded RNA-dependent protein kinase (PKR) is regulated by reovirus structural proteins. Virology 1997;234: 364-371.
544. Yue Z, Shatkin AJ. Regulated, stable expression and nuclear presence of retrovirus double-stranded RNA-binding protein σ3 in HeLa cells. J Virol 1996;70:3497-3501.
545. Zarbl H, Skup S, Millward S. Reovirus progeny subviral particles synthesize uncapped mRNA. J Virol 1980;34:497-505.
546. Zhang C, Liu L, Wang P, et al. A potentially novel reovirus isolated from swine in northeastern China in 2007. Virus Genes 2011;43:342-349.
547. Zhang L, Chandran K, Nibert ML, et al. Reovirus μ1 structural rearrangements that mediate membrane penetration. J Virol 2006;80:12367-12376.
548. Zhang P, Samuel CE. Protein kinase PKR plays a stimulus- and virus-dependent role in apoptotic death and virus multiplication in human cells. J Virol 2007;81:8192-8200.
549. Zhang X, Ji Y, Zhang L, et al. Features of reovirus outer capsid protein μ1 revealed by electron cryomicroscopy and image reconstruction of the virion at 7.0 Å resolution. Structure 2005;13:1545-1557.
550. Zhang X, Walker SB, Chipman PR, et al. Reovirus polymerase λ3 localized by cryo-electron microscopy of virions at a resolution of 7.6 A. Nat Struct Biol 2003;10:1011-1018.
551. Zhang Z, Kim T, Bao M, et al. DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells. Immunity 2011;34:866-878.
552. Zhang Z, Yuan B, Lu N, et al. DHX9 pairs with IPS-1 to sense double-stranded RNA in myeloid dendritic cells. J Immunol 2011;187:4501-4508.
553. Zou S, Brown EG. Identification of sequence elements containing signals for replication and encapsidation of the reovirus M1 genome segment. Virology 1992;186:377-388.
554. Zou S, Brown EG. Stable expression of the reovirus μ2 protein in mouse L cells complements the growth of a reovirus ts mutant with a defect in its M1 gene. Virology 1996;217:42-48.
555. Zurney J, Howard KE, Sherry B. Basal expression levels of IFNAR and Jak-STAT components are determinants of cell-type-specific differences in cardiac antiviral responses. J Virol 2007;81:13668-13680.
556. Zurney J, Kobayashi T, Holm GH, et al. The reovirus μ2 protein inhibits interferon signaling through a novel mechanism involving nuclear accumulation of interferon regulatory factor 9. J Virol 2009;83:2178-2187.
557. Zweerink HJ, Ito Y, Matsuhisa T. Synthesis of reovirus double-stranded RNA within virion-like particles. Virology 1972;50:349-358.
558. Zweerink HJ, McDowell MJ, Joklik WK. Essential and non-essential non-capsid reovirus proteins. Virology 1971;45:716-723.